Tarsus Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.54 M | $195.95 M | -5.77% | 9.22% |
| RTW INVESTMENTS, LP | 02/14/2025 | 3.24 M | $179.21 M | -5.16% | 8.43% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 2.53 M | $140.19 M | 3.75% | 6.60% |
| JENNISON ASSOCIATES LLC | 01/24/2025 | 2.50 M | $138.43 M | 14.76% | 6.51% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 2.25 M | $124.85 M | 0.00% | 5.87% |
| VANGUARD GROUP INC | 02/11/2025 | 2.12 M | $117.12 M | 0.85% | 5.51% |
| MORGAN STANLEY | 02/14/2025 | 1.97 M | $109.03 M | -10.84% | 5.13% |
| TORONTO DOMINION BANK | 02/19/2025 | 1.91 M | $105.71 M | 100.00% | 4.97% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 1.59 M | $87.90 M | 0.00% | 4.14% |
| LORD, ABBETT & CO. LLC | 02/14/2025 | 1.28 M | $70.87 M | 115.17% | 3.33% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 1.15 M | $63.50 M | 0.49% | 2.99% |
| INVESCO LTD. | 02/13/2025 | 932,115 | $51.61 M | 36.65% | 2.43% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 838,804 | $46.46 M | 0.36% | 2.19% |
| MACQUARIE GROUP LTD | 02/14/2025 | 815,912 | $45.18 M | 37.16% | 2.13% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/12/2025 | 691,299 | $38.28 M | -2.50% | 1.80% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 644,010 | $35.66 M | 189.42% | 1.68% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 607,689 | $33.65 M | -41.02% | 1.58% |
| ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 570,056 | $31.56 M | -2.89% | 1.49% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 500,000 | $27.69 M | 0.00% | 1.30% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 460,773 | $25.51 M | 92.54% | 1.20% |
| JEFFERIES FINANCIAL GROUP INC. | 02/27/2025 | 420,758 | $23.30 M | 0.00% | 1.10% |
| GILDER GAGNON HOWE & CO LLC | 02/14/2025 | 404,237 | $22.38 M | 5,636.30% | 1.05% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 365,544 | $20.24 M | 100.74% | 0.95% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 350,000 | $19.38 M | -6.67% | 0.91% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 341,305 | $18.90 M | -15.51% | 0.89% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 318,730 | $17.65 M | 18.59% | 0.83% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 293,700 | $16.26 M | 1.27% | 0.77% |
| JANE STREET GROUP, LLC | 02/14/2025 | 266,600 | $14.76 M | 100.00% | 0.69% |
| AIGH CAPITAL MANAGEMENT LLC | 02/12/2025 | 224,713 | $12.44 M | 9.93% | 0.59% |
| TFG ASSET MANAGEMENT GP LTD | 02/21/2025 | 200,000 | $11.07 M | -67.43% | 0.52% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 186,662 | $10.34 M | -85.60% | 0.49% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 01/29/2025 | 181,122 | $10.03 M | -13.97% | 0.47% |
| ATIKA CAPITAL MANAGEMENT LLC | 02/13/2025 | 177,200 | $9.81 M | 100.00% | 0.46% |
| ALLY BRIDGE GROUP (NY) LLC | 02/14/2025 | 173,144 | $9.59 M | -46.21% | 0.45% |
| SANDS CAPITAL VENTURES, LLC | 02/13/2025 | 170,000 | $9.41 M | 0.00% | 0.44% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 156,403 | $8.66 M | -43.24% | 0.41% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 153,441 | $8.50 M | 93.82% | 0.40% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 148,735 | $8.24 M | 43.71% | 0.39% |
| BAIRD FINANCIAL GROUP, INC. | 02/14/2025 | 142,419 | $7.89 M | -2.74% | 0.37% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 136,795 | $7.57 M | -5.88% | 0.36% |
| J. GOLDMAN & CO LP | 02/14/2025 | 130,195 | $7.21 M | -76.65% | 0.34% |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 02/05/2025 | 130,097 | $7.20 M | -0.27% | 0.34% |
| JPMORGAN CHASE & CO | 02/12/2025 | 129,184 | $7.15 M | -70.65% | 0.34% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 125,539 | $6.95 M | -10.79% | 0.33% |
| CUTTER CAPITAL MANAGEMENT, LP | 02/14/2025 | 112,500 | $6.23 M | 100.00% | 0.29% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 110,889 | $6.14 M | 100.00% | 0.29% |
| WOODLINE PARTNERS LP | 02/14/2025 | 108,986 | $6.03 M | 52.28% | 0.28% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 101,928 | $5.64 M | 0.49% | 0.27% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 97,996 | $5.43 M | 51.50% | 0.26% |
| LISANTI CAPITAL GROWTH, LLC | 02/07/2025 | 96,935 | $5.37 M | 143.28% | 0.25% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Tarsus Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 207 institutional investors and hedge funds held shares of Tarsus Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 3.54 M
RTW INVESTMENTS, LP: 3.24 M
Paradigm Biocapital Advisors LP: 2.53 M
JENNISON ASSOCIATES LLC: 2.5 M
TANG CAPITAL MANAGEMENT LLC: 2.25 M
VANGUARD GROUP INC: 2.12 M
104.51% of Tarsus Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 45.78 M shares in the last 24 months. This purchase volume represents approximately $2.17 B in transactions.